Filing Details

Accession Number:
0001144204-13-031179
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 21:30:33
Reporting Period:
2013-05-20
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 21:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353128 Gayle Barbara Duncan C/O Intercept Pharmaceuticals, Inc.
18 Desbrosses Street
New York NY 10013
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-20 4,327 $21.50 11,141 No 4 M Direct
Common Stock Acquisiton 2013-05-20 23,873 $8.67 35,014 No 4 M Direct
Common Stock Disposition 2013-05-20 28,000 $34.50 7,014 No 4 S Direct
Common Stock Disposition 2013-05-20 100 $34.50 6,914 No 4 S Direct
Common Stock Disposition 2013-05-20 100 $34.50 6,814 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to Purchase Common Stock Disposition 2013-05-20 4,327 $0.00 4,327 $21.50
Common Stock Options to Purchase Common Stock Disposition 2013-05-20 23,873 $0.00 23,873 $8.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,519 2022-11-16 No 4 M Direct
23,722 2020-08-16 No 4 M Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 20, 2013.
  2. 2.0833% of shares originally underlying the option vest on a monthly basis through January 1, 2016, subject to the terms and conditions of the award and the Issuer's 2012 Equity Incentive Plan.
  3. 2.0833% of shares originally underlying the option vest on a monthly basis through December 31, 2013, subject to the terms and conditions of the award and the Issuer's 2003 Stock Incentive Plan.